January 30, 2019
Feasibility Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Read More
January 30, 2019
Feasibility Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Read More
January 30, 2019
A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine
Read More
X